[1]Neuschwander-Tetri, B. A.Caldwell, S. H. Nonalcoholic steatohepatitis: summary of an AASLD Single Topic Conference[J].Hepatology,2003,37(5):1202-1219.
[2]曾民德.葡萄糖毒性、脂肪毒性与非酒精性脂肪性肝病[J].中华肝脏病杂志,2005,13(2):81-82.
[3]Angulo P.Nonalocoholic fatty liver disease[J].NEngl J Med,2002,346(16):1221-1231.
[4]Silverman JF,Pories WJ,Caro JF.Liver pathology in di-abetes mellitusand morbid obesity:clinical,pathological and biochemical considerations[J].Pathol Annu,1989,24:275-302.
[5]范建高.非酒精性脂肪肝的临床流行病学研究[J].中华消化杂志,2002,22(2):106-107.
[6]Dixon JB, Bhathal PS, O’Brien PE. Nonalcoholic fatty liver disease: Predictors of nonalcoholic steatohepatitis and liver fibrosis in the severely obese[J]. Gastroenterology, 2001,121(1):91-100.
[7]Pagano G, Pacini G, Musso G, et al. Nonalcoholic steatohepatitis, insulin resistance, and metabolic syndrome: Further evidence for an etiologic association[J]. Hepatology,2002,35(2):367-372.
[8]Neuschwander-Tetri BA.Evolving pathophysiologic concepts in nonalcoholic steatohepatitis[J]. Curr Gastroenterol Rep, 2002,4(1):31-36.
[9]Weltman MD,Farrell GC,Liddle C. Increased hepatocyte CYP2E1 expression in a rat nutritional model of hepatic steatosis with inflammation[ J]. Gastroenterology, 1996,111(6): 1645-1653.
[10]Chitturi S,Farrell GC. Etiopathogenesis of nonalcoholic-steatohepatitis[J]. Semin Liver Dis, 2001,21(1): 27-41.
[11]Gochee PA, Jonsson JR, Clouston AD, et al Steatosis in chronic hepatitis C:association with increased messenger RNA expression of collagen I,tumor necrosis factor-alpha and cytoc hrome P4502E1[J]. J Gastroenterol Hepatol,2003, 18(4): 386-392.
[12]Starkel P, Sempoux C,Leclercq I,et al.Oxidative stress,KLF6 and transforming growth factor-β up-regulation differentiate nonalcoholic steatohepatitis progressing to fibrosis from uncomplicated steatosis in rats[J]. J Hepatology, 2003, 39(4): 538-546.
[13]Chitturi S,Farrell G,Frost L.et al. Serum leptin in NASH correlates with hepatic steatosis but not fibrosis: a manifestation of lipotoxicity[J]? Hepatology, 2002,36(2): 403-409.
[14]Wigg AJ,Roberts-Thomson IC,Dymock RB,et al.The role of small intestinal bacterial overgrowth, intestinal permeability, endotoxaemia, and tumour necrosis factor alpha in the pathogenesis of non-alcoholic steatohepatitis[J].Gut,2001, 48(2): 206-211.
[15]Crespo J,Cayon A,Fernandez-Gil P,et al.Gene expression of tumor necrosis factor alpha and TNF-receptors, p55 and p75, in nonalcoholic steatohepatitis patients[J].Hepatology,2001,34(6):1158-1163.
[16]Shimizu A, Takamura T,Matsuzawa N,et al.Regulation of adiponectin receptor expression in human liver and a hepatocyte cell line[J]. Metabolism,2007,56(11):1478-1485.
[17]Xu A,Wang Y,Keshaw H, et al. The fat-derived hormone adiponectin alleviates alcoholic and nonalcoholic fatty liver diseases in mice[J]. J Clin Invest, 2003, 112(1):91-100.
[18]Fishman S, Muzumdar RH, Atzmon G,et al.Resistance to leptin action is the major determinant of hepatic triglyceride accumulation in vivo[J].Faseb J,2007,21(1): 53-60.
[19]Akiyama T, Tachibana I,Shirohara H,et al.High-fat hypercaloric diet induces obesity,glucose intolerance and hyperlipidemia in normal adult male Wistar rat[J].Diabetes Res Clin Pract,1996,31(1-3):27-35.
[20]Cavanilles WE,Solar BA,Garcia AL,et al. Effectiveness of weight loss in the treatment of non-alcoholic steatohepatitis in an obese adolescent [J].An Pediatr (Barc) 2007,66(2):184-187.
[21]Comar KM,Sterling RK.Drug threapy for non-alcoholic fatty liver disease[J].Aliment pharmacal Thea,2006,23(2):207-215.
[22]Uygun A,Kadayifci A,Isik AT,et al.Metformin in the treatment of patients with non-alcoholic steatohepatitis[J].Aliment Pharmacol Ther,2004,19(5)∶537-544.
[23]Promrat K,Lutchman G,Uwaifo GI,et al.A pilot study of pioglitazone treatment for nonalcoholic steatohepatitis[J].Hepatology,2004,39(1)∶188-196.
[24]May LD,Lefkowitch JH, Kram MT,et al.Mixed hepatocellular-cholestatic liver injury after pioglitazone therapy[J]. Ann Intern Med, 2002,136(6):449-452.
[25]Newberne PM, Bresnahan MR,Kula N.Effects of two synthetic antioxidants, vitamin E, and ascorbic acid on the choline-deficient rat[J].J Nutr,1969,97(2):219-231.
[26]Lavine JE.Vitamin E treatment of nonalcoholic steatohepatitis in children:a pliot study[J].J Pediatr,2000,136(6)∶734-738.
[27]Keith D,Lindor Kris V,Kowdiey E,et al.Ursodexycholic acid for treatment of nonalcoholic steatopatitis:results of a randomized trial[J].Hepatology,2004,39(3)∶770-778.
[28]Abdelmalek MF,Angulo P,Jorgensen RA,et al.Betain,a promising new agent of patients with nonalcoholic steatoheptitis:results of a pilot study[J].Am J Gastroenterol,2001,96(9)∶2711-2717.
[29]Angulo Paul.Nonalcoholic fatty liver disease and liver transplantation[J]. Liver Transplantation, 2006,12(4):523-534.
[30]Burke A,FitzGerald GA,Lucey MR.A prospective analysis of oxidative stress and liver transplantation[J]. Transplantation,2002,74(2):217-221.
[1]王 颖,钟 勇,史兆荣,等.中青年非酒精性脂肪肝与代谢综合征的关系[J].医学研究与战创伤救治(原医学研究生学报),2012,14(02):144.
[2]祝春华,舒荣文,刘志军,等.替米沙坦对部分中老年高血压病胰岛素抵抗及糖、脂代谢的影响[J].医学研究与战创伤救治(原医学研究生学报),2012,14(03):230.
ZHU Chun-hua,SHU Rong-wen,LIU Zhi-jun,et al.Effect of telmisartan on insulin resistance and glucose and lipid metabolism in the middle-aged and elderly patients with hypertension[J].JOURNAL OF MEDICALRESEARCH —COMBAT TRAUMA CARE,2012,14(04):230.
[3]黄艳,赵亚萍综述,王加林审校.肥胖相关胰岛素抵抗分子机制的研究进展[J].医学研究与战创伤救治(原医学研究生学报),2010,12(06):526.
[4]吴静静,刘锦霞,吴元赭,等.观察二甲双胍和螺内酯对多囊卵巢
综合征患者ghrelin的影响[J].医学研究与战创伤救治(原医学研究生学报),2009,11(04):289.
WU Jing-jing,LIU Jin-xia,WU Yuan-zhe,et al.Studies on effects of Metformin and Spironolactone on plasma ghrelin in polycystic ovary syndrome[J].JOURNAL OF MEDICALRESEARCH —COMBAT TRAUMA CARE,2009,11(04):289.
[5]蒋克春,饶亚平,王爱萍,等.系统性红斑狼疮合并严重胰岛素抵抗1例[J].医学研究与战创伤救治(原医学研究生学报),2008,10(03):214.
[6]徐晓峰,徐英美,蔡缨,等.低血糖指数膳食对代谢综合征患者体重
指数、腰臀比值及内脏脂肪的影响[J].医学研究与战创伤救治(原医学研究生学报),2008,10(04):261.
XU Xiao-feng,XU Ying-mei,CAI Ying,et al.Effect of low glycemic index diet on body mass index, waist/hip ratio and visceral fat in metabolic syndrome patients[J].JOURNAL OF MEDICALRESEARCH —COMBAT TRAUMA CARE,2008,10(04):261.
[7]周 江,文 萍,肖秋金.老年2型糖尿病患者心脏功能改变与胰岛素抵抗的关系[J].医学研究与战创伤救治(原医学研究生学报),2014,16(03):308.[doi:10.3969/j.issn.1672-271X.2014.03.028]
[8]杨小骏,张海,金华.阻塞性睡眠呼吸暂停与非酒精性脂肪性肝病的关系研究[J].医学研究与战创伤救治(原医学研究生学报),2014,16(04):385.[doi:10.3969/j.issn.1672-271X.2014.04.016]
YANG Xiao-jun,ZHANG Hai,JIN Hua..Research between obstructive sleep apnea and nonalcoholic fatty liver disease[J].JOURNAL OF MEDICALRESEARCH —COMBAT TRAUMA CARE,2014,16(04):385.[doi:10.3969/j.issn.1672-271X.2014.04.016]
[9]谭擎缨,王秀景,姚佳琦,等.男性2型糖尿病患者胰岛素抵抗与前列腺特异性抗原的相关性研究[J].医学研究与战创伤救治(原医学研究生学报),2014,16(05):473.[doi:10.3969/j.issn.1672-271X.2014.05.008]
TAN Qing-ying,WANG Xiu-jing,YAO Jia-qi,et al.The association between insulin resistance and serum prostat specific antigen levels in male patients with type 2 diabetics[J].JOURNAL OF MEDICALRESEARCH —COMBAT TRAUMA CARE,2014,16(04):473.[doi:10.3969/j.issn.1672-271X.2014.05.008]
[10]王 宇,姜明霞,许 琦,等.低碳水化合物饮食对非酒精性脂肪肝肥胖患者的影响[J].医学研究与战创伤救治(原医学研究生学报),2015,17(01):5.[doi:10.3969/j.issn.1672-271X.2015.01.002]
WANG Yu,JIANG Ming-xia,XU Qi,et al.Effects of low-carbohydrate diet on obese adults with nonalcoholic fatty liver disease[J].JOURNAL OF MEDICALRESEARCH —COMBAT TRAUMA CARE,2015,17(04):5.[doi:10.3969/j.issn.1672-271X.2015.01.002]